Business & Finance
Agilent Appoints Varian Medical Systems CEO to Board of Directors
22 January 2018 - - Santa Clara, California application focused solutions provider Agilent Technologies Inc. (NYSE: A) has elected Dow R. Wilson, CEO of Varian Medical Systems, Inc., to its board of directors, effective March 20, 2018, the company said.
Since 2012 Wilson has been CEO of Varian Medical, a Palo Alto, Calif-based medical device and software products company for treating cancer.
Prior to his appointment as CEO, Wilson was COO and executive VP, and before that he was president of Varian Medical's Oncology Systems business.
Wilson also had a 19-year career with GE Healthcare, culminating in his position as CEO of GE's healthcare information technology unit.
Wilson received an MBA from the Tuck School of Business at Dartmouth College, New Hampshire, and a Bachelor of Arts degree from Brigham Young University, Utah.
Agilent partners with pharmaceutical companies to develop immunohistochemical-based diagnostics for cancer therapy.
The company provides instruments, software, services, and solutions to the life sciences, diagnostics and applied chemical markets. It generated revenues of USD 4.2bn in fiscal 2016 and employs about 13,000 people worldwide.